|
|
 |
2005 Archive
November 28, 2005
diaDexus And The Methodist Debakey Heart Center Announce Publication Of Data In JAMA's Archives Of Internal Medicine Demonstrating 11-Fold Increase In Stroke Risk Associated With Elevated Lp-PLA2 And CRP
November 15, 2005
Data Presented At AHA Scientific Sessions Demonstrate Major Risk Stratification Benefits Of Lp-PLA2 In Diabetic Patients And Those Presenting With Recurrent Acute Coronary Syndromes
November 14, 2005
Data Demonstrate Lp-PLA2 Is Better Predictor Of Cardiovascular Disease In Older Women Than CRP
November 7, 2005
diaDexus Announces Presentations Highlighting Role Of Lp-PLA2 In Cardiovascular Disease And Stroke At The Aha Scientific Sessions 2005
June 17, 2005
diaDexus Receives FDA Clearance To Market The PLAC® Test For Assessing Risk Of Stroke
April 15, 2005
diaDexus Announces Presentations on Novel Cancer Markers at the 96th Annual Meeting of the American Association for Cancer Research
April 15, 2005
diaDexus Appoints Richard B. Lanman, M.D., to Executive Team
March 8, 2005
Data Presented At ACC Scientific Sessions 2005 Demonstrate Elevated Lp-PLA2 Levels Predict Cardiovascular Events
Second Study Highlights Lp-PLA2 as a Predictor of Ischemic Death and Angiographic Coronary Artery Disease
March 4, 2005
diaDexus Announces Presentations Highlighting The Role Of Lp-PLA2 In Cardiovascular Disease At The American College Of Cardiology Scientific Sessions 2005
March 2, 2005
diaDexus Submits 510 (k) Premarket Notification to FDA for PLAC® Test for Stroke Risk Assessment
January 11, 2005
Study Supports Lp-PLA2 as Measured by diaDexus PLAC® Test as an Independent Risk Predictor of Coronary Events and Strokes
Publication in European Heart Journal Demonstrates Elevated Lp-PLA2 levels are associated with a Higher Incidence of Major Adverse Events Independent of Traditional Risk Factors and CRP
|
|
|
|
